Larson Financial Group LLC Has $181,000 Position in Waters Co. (NYSE:WAT)

Larson Financial Group LLC raised its position in Waters Co. (NYSE:WAT) by 59.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 503 shares of the medical instruments supplier’s stock after acquiring an additional 188 shares during the quarter. Larson Financial Group LLC’s holdings in Waters were worth $181,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in Waters in the second quarter valued at $33,000. Kennebec Savings Bank acquired a new stake in Waters in the third quarter valued at $33,000. Blue Trust Inc. lifted its stake in Waters by 190.2% in the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 78 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Waters during the 3rd quarter worth about $35,000. Finally, TFC Financial Management Inc. lifted its stake in shares of Waters by 19,900.0% during the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 199 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

WAT has been the subject of a number of research reports. Evercore ISI raised their target price on shares of Waters from $335.00 to $355.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. The Goldman Sachs Group upgraded shares of Waters to a “hold” rating in a research note on Wednesday, July 31st. Jefferies Financial Group upgraded shares of Waters from a “hold” rating to a “buy” rating and raised their target price for the stock from $355.00 to $415.00 in a research note on Tuesday, October 8th. Leerink Partners upgraded shares of Waters from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $325.00 to $375.00 in a research note on Thursday, August 1st. Finally, Cfra set a $389.00 price objective on shares of Waters in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $365.85.

Waters Trading Down 0.4 %

Shares of Waters stock opened at $386.57 on Thursday. The firm has a market capitalization of $22.95 billion, a PE ratio of 36.89, a price-to-earnings-growth ratio of 6.92 and a beta of 0.97. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The firm’s 50 day moving average is $356.22 and its 200 day moving average is $332.60. Waters Co. has a 1 year low of $273.60 and a 1 year high of $395.44.

Waters (NYSE:WAT) last announced its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.84 EPS. Equities research analysts forecast that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.